Team claims to have ID'd epilepsy 'switch'; Stem cells used to grow hair; Israeli researchers probe role of neutrophils in cancer;

> Researchers working with the University of Bonn Hospital say they have identified a central switch behind epilepsy. Their target: the molecule sestrin-3. Release

> Sanford-Burnham Medical Research Institute researchers say they have used human pluripotent stem cells to generate new hair. Release

> Investigators at Hebrew University of Jerusalem have been researching the role of neutrophils (white blood cells) in fighting and promoting cancer. "The novel distinction between harmful and beneficial neutrophils opens up new diagnostic and therapeutic opportunities," says Dr. Zvika Grano. "We are currently evaluating the effects of boosting the helpful anti-tumor neutrophil population, while limiting the tumor-promoting neutrophil population, on progression of the disease. If successful, this therapeutic strategy may take us closer to developing effective new therapies for cancer." Release

> The growing number of drug projects targeting celiac disease can look to a growing patient population. According to one new study disease rates for the food allergy have nearly tripled in the past 20 years. Release

Suggested Articles

Researchers discovered that inactivating a subtype of the protein beta-arrestin-2 in mice restored the ability of the brain to dispose of toxic tau.

A newfound link between BMAL1, a protein involved in circadian rhythms, and triple-negative breast cancer could point to new treatment strategies.

Combining a DYRK1A inhibitor with popular GLP-1 receptor agonists regenerates insulin-producing beta cells, Mount Sinai scientists found.